3 transcripts
VRNA
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
that's the goal, and those are some of the endpoints that we'll be assessing in this first trial.
Great. But do you have any preclinical data to support what
VRNA
Earnings call transcript
NASDAQ
2024 Q1
9 May 24
programs Dave discussed a few moments ago.
Let me spend a minute discussing key terms of the financing package. Our primary goal in establishing this new
VRNA
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
substantial progress towards our goal of bringing ensifentrine to COPD patients with the submission of a new drug application to the FDA for nebulized
- Prev
- 1
- Next